Laboratory of Experimental Endocrinology, University of Crete, School of Medicine, Heraklion, Greece.
Laboratory of Experimental Endocrinology, University of Crete, School of Medicine, Heraklion, Greece.
Mol Cell Endocrinol. 2022 Jan 1;539:111487. doi: 10.1016/j.mce.2021.111487. Epub 2021 Oct 8.
In prostate cancer, calcium homeostasis plays a significant role in the disease's development and progression. Intracellular calcium changes are an important secondary signal, triggered by a variety of extracellular stimuli, that controls many cellular functions. One of the main events affecting calcium is androgen signaling. Indeed, via calcium changes, androgens regulate cell processes like cell growth, differentiation and motility. In the present work we explored the nature of the receptor involved in calcium response induced by membrane-acting testosterone in prostate cancer cells. We report that testosterone, independently of the presence of the classical androgen receptor, can rapidly increase intracellular calcium from calcium stores, through the oxoeicosanoid receptor 1 (OXER1) and a specific signaling cascade that triggers calcium release from the endoplasmic reticulum. These findings reveal for the first time the receptor involved in the rapid calcium changes induced by androgens. Moreover, they further support the notion that androgens, even in the absence of AR, can still exert specific effects that regulate cancer cell fate.
在前列腺癌中,钙稳态在疾病的发展和进展中起着重要作用。细胞内钙变化是一种重要的次级信号,由各种细胞外刺激触发,控制许多细胞功能。影响钙的主要事件之一是雄激素信号。事实上,通过钙变化,雄激素调节细胞生长、分化和运动等细胞过程。在本工作中,我们探索了参与膜作用睾酮诱导的前列腺癌细胞钙反应的受体性质。我们报告说,睾酮可以独立于经典雄激素受体,通过环氧二十碳三烯酸受体 1(OXER1)和触发内质网钙释放的特定信号级联,快速增加细胞内钙库中的细胞内钙。这些发现首次揭示了雄激素诱导的快速钙变化所涉及的受体。此外,它们进一步支持这样一种观点,即雄激素,即使在缺乏 AR 的情况下,仍然可以发挥调节癌细胞命运的特定作用。